Evidence map›Paper›PMID 32764932›Full record

ArticleInternational journal of nanomedicine2020

Gold Nanoparticles Perturb Drug-Metabolizing Enzymes and Antioxidants in the Livers of Male Rats: Potential Impact on Drug Interactions.

Mohammed Y I Al-Hamadani, Abdullah M Alzahrani, Mokhtar I Yousef, Maher A Kamel, Wael M El-Sayed

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mohammed Y I Al-HamadaniDepartment of Zoology Faculty of Science, Ain Shams University, Cairo 11566, Egypt.
Abdullah M AlzahraniDepartment of Biological Sciences, King Faisal University, Ahsaa, Saudi Arabia.ORCID 0000-0003-4372-4968
Mokhtar I YousefDepartment of Environmental Studies, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.ORCID 0000-0002-5652-2719
Maher A KamelDepartment of Biochemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt.ORCID 0000-0002-6791-9850
Wael M El-SayedDepartment of Zoology Faculty of Science, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0002-3622-1417
Ain Shams University · EGAlexandria University · EGKing Faisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimWith the wide applications of chitosan and gold nanoparticles in drug delivery and many consumer products, there is limited available information about their effects on drug-metabolizing enzymes (DMEs). Changes in DMEs could result in serious drug interactions. Therefore, this study aimed to investigate the effects of exposure to chitosan or gold nanoparticles on hepatic Phase I and II DMEs, liver function and integrity, oxidative damage and liver architecture in male rats.

methodsAnimals were divided into three equal groups: a control group, a group treated with chitosan nanoparticles (200 mg/kg, 50±5 nm) and a group treated with gold nanoparticles (4 mg/kg, 15±5 nm). Rats were orally administered their respective doses daily for 10 days.

resultsBoth chitosan and gold nanoparticles decreased the body weights by more than 10%. Gold nanoparticles reduced the activities of antioxidants (superoxide dismutase and catalase), and reduced glutathione level and elevated the malondialdehyde level in the liver. Gold nanoparticles caused significant reductions in CYP1A1, CYP2E1, quinone oxidoreductase1, and glutathione S-transferase and elevated CYP2D6 and N-acetyl transferase2. Chitosan elevated CYP2E1 and CYP2D6 and reduced UDP-glucuronosyltransferase 1A1. Both nanoparticles disturbed the architecture of the liver, but the deleterious effects after gold nanoparticles treatment were more prominent.

conclusionTaken together, gold nanoparticles severely perturbed the DMEs and would result in serious interactions with many drugs, herbs, and foods.

Indexed as

AnimalsAntioxidantsCatalaseChitosanCytochrome P-450 CYP1A1Cytochrome P-450 CYP2E1Drug InteractionsGene Expression Regulation, EnzymologicGlucuronosyltransferaseGlutathioneGlutathione TransferaseGoldInactivation, MetabolicLiverMaleMalondialdehydeAntioxidantsCatalaseChitosanCytochrome P-450 CYP1A1Cytochrome P-450 CYP2E1GlucuronosyltransferaseGlutathioneGlutathione TransferaseGoldMalondialdehydeSuperoxide DismutaseUGT1A1 EnzymechitosanCYP450drug interactionsdrug metabolizing enzymesoxidative stress

Identifiers

PMID32764932
PMCPMC7369367
OpenAlexW3041843249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.